• Akiyuki Uzawa, Masahiro Mori, Setsu Sawai, Saeko Masuda, Mayumi Muto, Tomohiko Uchida, Shoichi Ito, Fumio Nomura, and Satoshi Kuwabara.
• Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan. auzawa@chiba-u.jp
• Clin. Chim. Acta. 2013 Jun 5;421:181-3.

BackgroundThe current 2006 neuromyelitis optica (NMO) criteria is useful for diagnosing NMO, however this criteria seemed to be insufficient at early stage of NMO. Hence, the development of diagnostic marker besides anti-aquaporin 4 antibody at early stage of NMO may be required. Our main aim of this study is to test the usefulness of measuring cerebrospinal fluid (CSF) interleukin (IL)-6 and glial fibrillary acidic protein (GFAP) concentrations as early diagnostic markers during initial NMO attacks.MethodsWe investigated CSF IL-6 and GFAP concentrations in 13 NMO spectrum disorder (NMOSD) patients at initial attacks, 24 idiopathic central nervous system inflammatory disease patients (9 optic neuritis, 9 myelitis and 6 encephalitis) and 20 other non-inflammatory neurological disorders (ONNDs) patients, retrospectively.ResultsThe mean CSF IL-6 and GFAP concentrations during the initial NMOSD attack were 91.4 pg/ml and 369.3 ng/ml, respectively, and were significantly higher than in ONNDs, idiopathic optic neuritis and myelitis patients (P<0.01). The sensitivity of high CSF IL-6 during initial NMO attack was 76.9% and that of high CSF GFAP was 84.6%, respectively.ConclusionOur data suggests that CSF IL-6 and GFAP may be useful early diagnostic markers of NMOSD.Copyright © 2013 Elsevier B.V. All rights reserved.

30 keywords...

hide…